InvestorsHub Logo
Followers 7
Posts 564
Boards Moderated 0
Alias Born 08/27/2014

Re: jessellivermore post# 37017

Wednesday, 10/22/2014 11:45:26 AM

Wednesday, October 22, 2014 11:45:26 AM

Post# of 425912
JL, after listening to the sept 16 webcast on reduce it completion, Thero states he will not detail plans for the anchor appeal, although he recognizes the outrage expressed by elected officials, investors, clinicians and patients. He then states Amarin continues to work with regulatory, clinical and legal resources as to a course of action. What I find even more curious than the status of the appeal process, is the FDA's lack of response to the question of the sNDA....as Amarin has made repeated attempts to get a decision on this matter from the FDA to no avail. Why is the sNDA in limbo?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News